1) preoperative chemotherapy
手术前化疗
2) Preoperative chemotherapy
术前化疗
1.
Relation between preoperative chemotherapy and expression of p27 and Ki67 in tissues of esophageal carcinoma;
食管癌术前化疗与p27及Ki67表达的关系
2.
Histopathologic Change of Breast Cancer Caused by Preoperative Chemotherapy and Its Molecular Mechanism;
术前化疗后乳腺癌组织病理学改变及其分子基础
3) Neoadjuvant chemotherapy
术前化疗
1.
To investigate effect of neoadjuvant chemotherapy on advanced mucous and serum epithe-lial ovarian cancer.
[目的]探讨术前化疗在晚期卵巢黏液性和浆液性上皮癌治疗中的作用。
4) surgery and chemotherapy
化疗后手术
1.
Analysis of prognostic factors in patients with non-small cell lung cancer treated by surgery and chemotherapy;
所以本文目的在于探讨先化疗后手术对NSCLC预后因素的影响。
5) preoperative radiochemotherapy
术前放化疗
1.
Objective To assess the impact of short-term preoperative radiochemotherapy in low rectal cancer.
方法对22例低位直肠癌患者进行术前放化疗。
2.
【Objective】To investigate efficacy of preoperative radiochemotherapy with anal sphincter preserving operation in T3 middle-low rectal cancer.
术前放化疗完成后4～6周进行手术,行TME切除加保肛手术,12例采用前切除吻合器吻合法,24例采用套入式结肠直肠黏膜吻合术。
6) Preoperative chemoradiotherapy
术前放化疗
1.
Conclusion Preoperative chemoradiotherapy has no significant impact on cellular immune function in elderly patients with colorectal cancer,it is an effective and safe treatment methods.
结果术前放化疗前后,患者外周血CD3+、CD4+、CD8+、CD4+/CD8+及NK细胞水平无明显差异(P>0。
2.
Conclusion Preoperative chemoradiotherapy can change the positive expression rate of MVD in the mid and low rectal cancer(TNM stage III and IV) without increasing the difficulty of operation and the incidence of postoperative complications.
目的结合微血管密度(MVD)改变,评价术前放化疗对中低位直肠癌中的临床疗效。
补充资料：尺神经前移手术
尺神经前移手术
anterior transposition of ulnar nerve
是将尺神经从肘管分离出来，松解其嵌顿后，移到肘关节前方，以清除屈肘时牵拉神经的作用，同时可改善其血运。此手术适用于治疗肘外翻畸形引起尺神经肘管嵌压综合征者。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条